Cite
HARVARD Citation
Boremalm, M. et al. (2019). Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis. European journal of neurology. pp. 1060-1067. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Boremalm, M. et al. (2019). Natalizumab, rituximab and fingolimod as escalation therapy in multiple sclerosis. European journal of neurology. pp. 1060-1067. [Online].